Skip to main content

Table 3 Adverse Events

From: Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer

Adverse Event

Grade 1

Grade 2

Grade 3

Blistering

2 (4.5%)

0

1 (2.3%)

Bruising

1 (2.3%)

0

0

Desquamation, Dry

1 (2.3%)

1 (2.3%)

0

Desquamation, Moist

1 (2.3%)

0

2 (4.5%)

Drainage, Serosanguinous

1 (2.3%)

0

0

Dry Skin (Breast)

2 (4.5%)

0

0

Ecchymosis

1 (2.3%)

0

0

Erythema, redness/rash

19 (43.2%)

8 (18.2%)

0

Fatigue

2 (4.5%)

4 (9.1%)

0

Fibrosis

1 (2.3%)

1 (2.3%)

0

Firmness (Breast tissue)

2 (4.5%)

0

0

Firmness (Skin)

2 (4.5%)

0

0

Hyperpigmentation / Hypopigmentation / Skin Discoloration

6 (13.6%)

3 (6.8%)

0

Induration

3 (6.8%)

0

0

Infection

0

2 (4.5%)

0

Itching / Pruritis

4 (9.1%)

0

0

Mass, 2.5 cm, non-calcified

1 (2.3%)

0

0

Pain (Rib)

1 (2.3%)

0

0

Pain / Tenderness / Discomfort

7 (15.9%)

5 (11.4%)

1 (2.3%)

Seroma

0

2 (4.5%)

0

Swelling

2 (4.5%)

0

0

Wound complication, non-infection

1 (2.3%)

0

0

  1. Number (%) of treated patients reporting each adverse event by CTC grade (N = 44)
  2. CTC = Common Terminology Criteria, cm = centimeter